Retina BioBank: Retina Biomarkers for a Deeper Understanding of Vitreoretinal and Systemic Diseases

Enrolling by invitation

Conditions studied: Other Retinal Disorders, Retinal Disease, Retinal Vascular Disorder

In brief

The RBBK study is a non-interventional, prospective study that will characterize disease state biomarker levels from aqueous humor, vitreous humor, intraoperative tissue and saliva of subjects with various retinal and systemic pathologies.

Key facts

Study ID

NCT06796673

Run by

Greater Houston Retina Research

People needed

10000

Starts

2022-04-11

Expected to finish

2032-08-01

Last updated by the study team

2025-01-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects with vitreoretinal disease in at least one eye receiving a retinal treatment intervention

You may not qualify if…

• Prior intraocular or subtenon steroid injection in the study eye within the prior 1 month of signing informed consent
• Intraocular or refractive surgery in the study eye within 30 days of signing informed consent
• Systemic anti-VEGF treatment within 90 days of signing informed consent

Where it is running

• Retina Consultants of Texas — Bellaire, Texas, United States
• Retina Consultants of Texas — Katy, Texas, United States
• Retina Consultants of Texas — The Woodlands, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.